3D-Matrix Medical
Regenerative medicine company with products that accelerate wound healing & tissue regeneration.
Launch date
Employees
Market cap
CAD113m
Enterprise valuation
CAD142m (Public information from Sep 2024)
Share price
JPY120 7777.T
Waltham Massachusetts (HQ)
Financials
Estimates*
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 672m | 1.0b | 1.5b | 2.3b | 4.6b |
| % growth | - | 52 % | 47 % | 54 % | 98 % |
| EBITDA | (2.9b) | (1.9b) | (1.8b) | (2.3b) | 236m |
| % EBITDA margin | (438 %) | (185 %) | (120 %) | (101 %) | 5 % |
| Profit | (3.1b) | (2.0b) | (1.9b) | (2.4b) | (256m) |
| % profit margin | (460 %) | (196 %) | (126 %) | (106 %) | (6 %) |
| R&D budget | 801m | 785m | 685m | 452m | 556m |
| R&D % of revenue | 119 % | 77 % | 45 % | 20 % | 12 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about 3D-Matrix Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.